Merck & Co Inc
NYSE: MRK
$96.56
+$0.25 (+0.3%)
Closing Price on November 18, 2024
MRK Articles
U.S. equity markets opened higher this morning following a slightly upbeat report on eurozone manufacturing PMI. While not yet in positive territory, eurozone PMI rose as a whole and rose in most...
Published:
Last Updated:
Jon OggThe bull market appears to still be alive and well for equities, but the risk of rising interest rates is plaguing bonds and investments tied to big dividends. What equity investors also need...
Published:
Last Updated:
ThinkstockShort sellers are have previously been all over the place when it comes to the high-yield dividend stocks. The May 15 settlement date is during what should have been (or could have been) a...
Published:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, May 28, 2013. They include Eli Lilly, W.R. Grace, Intelsat and GlaxoSmithKline.
Published:
Last Updated:
ThinkstockSony Corp. (NYSE: SNE) cuts forecasts for game console margins for the next several years. (MarketWatch) Sony also cuts targets for smartphones and camera sales. (Reuters) A complex Irish...
Published:
Last Updated:
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
Published:
Last Updated:
On the surface it looks like short sellers are all over the place in the latest short interest report. The April 30 settlement date is after many companies had their earnings reports. We saw some...
Published:
Last Updated:
U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from the Bureau of Labor Statistics will follow the ADP...
Published:
Last Updated:
Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many investors, what investors need to know...
Published:
Last Updated:
ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock is down more than 3%. Last week competitor Amgen Inc....
Published:
Last Updated:
This week should mark the climax of first quarter corporate earnings season. It will be a full week for the earnings calendar, along with key economic events and some corporate annual meetings to...
Published:
Last Updated:
While the current stock market rally has been impressive since the lows last November, many investors, analysts and equity strategists are casting a wary eye at the looming May 1 date. In a new...
Published:
Last Updated:
Jon OggShort sellers have increased their bets against some of the defensive high-yield dividend stocks, while paring down in others. As you will see, the dividend and stock performance matter here....
Published:
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
Published:
Last Updated:
Jon OggShort sellers may be getting smarter about all the inflows of capital heading into dividend stocks. The short interest fell in many of the names, but investors should understand that this...
Published: